Key points:
- Otha Smith started Tetragram, a company that collects data on cannabis users and their experiences.
- Tetragram uses a mobile app to let people record what they feel after using cannabis products.
- The app also helps to understand the effects of different ingredients in cannabis, like terpenes and cannabinoids.
- Tetragram wants to help consumers make better choices based on their needs and not just on how much THC a product has.
- Otha Smith used to take opioids but switched to plant-based medicines like cannabis. Read from source...

- The article focuses too much on the founder's personal story and not enough on Tetragram's actual data analysis methods and results. It seems like an attempt to appeal to the reader's empathy rather than provide factual information.
- The article uses vague terms such as "the why behind each customer's purchase" and "specific medical conditions and desired effects" without explaining how Tetragram measures or quantifies them. This creates a sense of uncertainty and lack of credibility in the claims made by the company and its founder.
- The article does not address any potential challenges or limitations that Tetragram may face in collecting, analyzing, and using consumer data in the cannabis industry. It also does not mention any competitors or alternative solutions that may exist in the market. This creates a one-sided and unrealistic portrayal of Tetragram's position and value proposition.

Positive

Summary:
The article discusses the story of Otha Smith, founder of Tetragram, a consumer data analytics company in the cannabis industry. It highlights how Tetragram is transforming data collection by providing consumers with a HIPAA-compliant mobile app to journal their cannabis experiences and understand the "why" behind each customer's purchase. The article also mentions Tetragram's collaborations with New Frontier Data, 40 Tons, and Stone Road Farms, as well as Smith's personal journey from opioid use to choosing medicinal plants.

Analysis:
The overall sentiment of the article is positive, as it portrays Tetragram as a pioneer in the cannabis consumer analytics space, providing valuable insights and solutions for both consumers and businesses. The article also praises Smith's vision and leadership, his journey from opioid use to plant-based medicines, and his commitment to social justice and diversity. Additionally, the article mentions Tetragram's collaborations with other industry leaders, which suggests a promising future for the company and the cannabis market as a whole.